MeSH Browser

MeSH Heading: Cyclic IMP
Tree Number(s): D03.633.100.759.646.616.300; D13.695.462.300; D13.695.667.616.300; D13.695.827.519.300
Unique ID: D007289
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D007289
Scope Note: Inosine cyclic 3',5'-(hydrogen phosphate). An inosine nucleotide which acts as a mild inhibitor of the hydrolysis of cyclic AMP and cyclic GMP and as an inhibitor of cat heart cyclic AMP phosphodiesterase.
Entry Version: CYCL IMP
Entry Term(s): Inosine Cyclic 3',5'-Monophosphate; Inosine Cyclic Monophosphate; Inosine Cyclic-3',5'-Monophosphate
CAS Type 1 Name: Inosine, cyclic 3',5'-(hydrogen phosphate)
Previous Indexing: Inosine Nucleotides (1971-1974); Nucleotides, Cyclic (1974)
Public MeSH Note: 94; was INOSINE CYCLIC MONOPHOSPHATE 1980-93 (see under INOSINE NUCLEOTIDES 1980-90), was INOSINE CYCLIC-3',5'-MONOPHOSPHATE see under INOSINE NUCLEOTIDES 1975-79; CYCLIC IMP was see INOSINE CYCLIC MONOPHOSPHATE 1975-93; INOSINE CYCLIC 2',3'-MONOPHOSPHATE was see INOSINE CYCLIC MONOPHOSPHATE 1980-93
Online Note: use CYCLIC IMP to search INOSINE CYCLIC MONOPHOSPHATE 1980-93 & INOSINE CYCLIC-3',5'-MONOPHOSPHATE 1975-79
History Note: 94; was INOSINE CYCLIC MONOPHOSPHATE 1980-93 (see under INOSINE NUCLEOTIDES 1980-90), was INOSINE CYCLIC-3',5'-MONOPHOSPHATE see under INOSINE NUCLEOTIDES 1975-79; CYCLIC IMP was see INOSINE CYCLIC MONOPHOSPHATE 1975-93; INOSINE CYCLIC 2',3'-MONOPHOSPHATE was see INOSINE CYCLIC MONOPHOSPHATE 1980-93
Date Established: 1991/01/01
Date of Entry: 1974/11/19
Revision Date: 2016/05/28

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

deficiency (DF)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

physiology (PH)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Heterocyclic Compounds [D03]
- Heterocyclic Compounds, Fused-Ring [D03.633]
  - Heterocyclic Compounds, 2-Ring [D03.633.100]
    - Purines [D03.633.100.759]
      - Purine Nucleotides [D03.633.100.759.646]
        
        Inosine Nucleotides [D03.633.100.759.646.616]
        
        Cyclic IMP [D03.633.100.759.646.616.300]
        
        Inosine Diphosphate [D03.633.100.759.646.616.400]
        
        Inosine Monophosphate [D03.633.100.759.646.616.500]
        
        Inosine Triphosphate [D03.633.100.759.646.616.800]

Nucleic Acids, Nucleotides, and Nucleosides [D13]
- Nucleotides [D13.695]
  - Nucleotides, Cyclic [D13.695.462]

Nucleic Acids, Nucleotides, and Nucleosides [D13]
- Nucleotides [D13.695]
  - Purine Nucleotides [D13.695.667]
    - Inosine Nucleotides [D13.695.667.616]

Nucleic Acids, Nucleotides, and Nucleosides [D13]
- Nucleotides [D13.695]
  - Ribonucleotides [D13.695.827]
    - Inosine Nucleotides [D13.695.827.519]

Cyclic IMP Preferred

Concept UI: M0011367
Scope Note: Inosine cyclic 3',5'-(hydrogen phosphate). An inosine nucleotide which acts as a mild inhibitor of the hydrolysis of cyclic AMP and cyclic GMP and as an inhibitor of cat heart cyclic AMP phosphodiesterase.
Terms: Cyclic IMP Preferred Term
Term UI T021843
Date01/01/1999
LexicalTag ACX
ThesaurusID NLM (1975); Inosine Cyclic-3',5'-Monophosphate
Term UI T021844
Date06/12/1985
LexicalTag NON
ThesaurusID UNK (19XX); Inosine Cyclic 3',5'-Monophosphate
Term UI T021845
Date06/12/1985
LexicalTag NON
ThesaurusID UNK (19XX); Inosine Cyclic Monophosphate
Term UI T021846
Date12/18/1992
LexicalTag NON
ThesaurusID NLM (1994)

Cyclic IMP MeSH Descriptor Data 2024